Sens. Press OMB For Delayed Medical Device Rule
In a letter directed to OMB Acting Director Jeffrey Zients, U.S. Sens. Herb Kohl, D-Wis.; Chuck Grassley, R-Iowa; and Richard Blumenthal, D-Conn., emphasized that the regulation could help the FDA bridge gaps in its medical device safety surveillance.
The FDA forwarded the so-called unique-device-identifier proposal to the OMB...
Already a subscriber? Click here to login